MarginsXMarginsX
Home › Markets › Health Care › BKHA

Black Hawk Acquisition Corporation (BKHA)

BKHA trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$7.20
-1.37% on the day
Market cap
Market cap not reported by the Nasdaq screener
Revenue
Blank-check company: no operating revenue
Net income
Blank-check company: no operating revenue

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerBKHA on Nasdaq
SectorHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
CountryUnited States
IPO year2024
SEC CIK0002000775
SEC industry codeBiological Products, (No Diagnostic Substances)

Financials

Blank-check company: no operating revenue.

Warning signs

Cash runway
0.0 months
$0 cash at August 31, 2026
Share count, 1 year
0.0%
2025-10-20 to 2026-10-06
Going-concern doubt
Yes
10-Q filed October 6, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"In connection with the Company's assessment of going concern considerations in accordance with Financial Accounting Standard Board's Accounting Standards Update ( ASU ) 2014-15, Disclosures of Uncertainties about an Entity's Ability to Continue as a Going Concern, management has determined that these conditions raise substantial doubt about the Company's ability to continue as a going concern."
10-Q 2026-10-06
Cash and burn$0 cash; operating cash flow -$140K a quarter.Report 2026-08-31
Shares outstanding4,153,577 (2026-10-06); 4,153,577 a year earlier.Cover page 2026-10-06
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-04-01
AuditorMaloneBailey, LLP, Houston, Texas, United StatesPCAOB Form AP 2026-03-16
Late filings, 12 months2 NT noticesNT 10-Q 2026-04-14
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-08-31
Not filed$1.1M-$113K$0$1.5MNeeds four quarters10-Q 2026-10-06
Q2 2026
2026-05-31
Not filed$89K-$237K$0$1.2MNeeds four quarters10-Q 2026-07-15
Q1 2026
2026-02-28
Not filed$140K-$110K$0$997KNeeds four quarters10-Q 2026-04-21
Q4 2025
2025-11-30
Not filed-$4K-$100K$0$595KNeeds four quarters10-K 2026-03-06
Q3 2025
2025-08-31
Not filed$154K-$108K$0$350KNeeds four quarters10-Q 2026-10-06
Q2 2025
2025-05-31
Not filed$521K-$279K$0No debt tagsNeeds four quarters10-Q 2026-07-15
Q1 2025
2025-02-28
Not filed$658K-$163K$0No debt tagsNeeds four quarters10-Q 2026-04-21
Q4 2024
2024-11-30
Not filed$752K-$59K$0$0Needs four quarters10-K 2026-03-06

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B42026-09-22
Latest annual report10-K/A2026-04-28
Latest quarterly / interim10-Q2026-10-06
Latest current report8-K2026-10-23
Latest proxyDEFA14A2025-07-08

Source: SEC EDGAR submissions feed, 120 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+29.7%
1 month-41.5%
3 months-38.0%
Year to date-35.1%
1 year-34.8%
From 52-week high-44.3%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Other listings for this company

TickerNamePrice
BKHARBlack Hawk Acquisition Corporation Rights$1.39
BKHAUBlack Hawk Acquisition Corporation Units$7.26

Peers in Biotechnology: Biological Products (No Diagnostic Substances)

TickerCompanyPriceDayMarket cap
ODTXOdyssey Therapeutics Inc.$19.36+1.15%$930.6M
IMTXImmatics N.V.$6.17-3.44%$923.2M
INBXInhibrx Biosciences Inc.$77.66-6.77%$1.1B
VORVor Biopharma Inc.$18.97-2.32%$1.2B
MGTXMeiraGTx Holdings plc$8.74-4.79%$854.2M
GLUEMonte Rosa Therapeutics Inc.$9.16-2.24%$782.7M
PRMEPrime Medicine Inc.$4.19-1.87%$762.3M
TSHATaysha Gene Therapies Inc.$4.06-0.98%$1.3B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier